سعر مالاركين 100مجم 10 اقراص 2026

Malarquine chloroquine phosphate 100 mg tablets, 10 tablets, antimalarial by El Nasr (Egypt); whether 100 mg refers to salt or base is not stated.

• Post-approval reactions include ocular disorders (maculopathy, irreversible retinopathy, visual disturbances, corneal opacities), urticaria/anaphylaxis, nerve-type deafness and tinnitus, myopathy/neuromyopathy, and other reactions listed in the label.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Use for indications other than acute malaria is contraindicated in the presence of retinal or visual field changes of any aetiology.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Known hypersensitivity to 4-aminoquinoline compounds.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Not effective against chloroquine- or hydroxychloroquine-resistant Plasmodium; resistance is widespread in P. falciparum and reported in P. vivax; do not use for complicated malaria.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Cardiomyopathy and QT prolongation: fatal and life-threatening cardiotoxicity (cardiomyopathy, conduction disorders, QT prolongation, torsades de pointes, ventricular arrhythmias) has been reported; risk is greater at high doses.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Severe, potentially life-threatening hypoglycaemia can occur with or without antidiabetic drugs; check blood glucose if symptoms occur.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Irreversible retinopathy: risk factors include daily doses above 2.3 mg/kg actual body weight (as phosphate), use beyond five years, reduced GFR, tamoxifen and macular disease; perform a baseline eye examination within the first year.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Antacids and kaolinAntacids and kaolin can reduce chloroquine absorption; separate intake by at least 4 hours.DailyMed (U.S. National Library of Medicine)
• CimetidineCimetidine can inhibit chloroquine metabolism and increase its plasma level; avoid concomitant use.DailyMed (U.S. National Library of Medicine)
• Insulin and other antidiabetic drugsChloroquine may enhance hypoglycaemic treatment; antidiabetic doses may need to be reduced.DailyMed (U.S. National Library of Medicine)
• Arrhythmogenic drugs (e.g. amiodarone, moxifloxacin)Increased risk of ventricular arrhythmias when chloroquine is combined with other arrhythmogenic drugs.DailyMed (U.S. National Library of Medicine)
• MefloquineCo-administration of chloroquine and mefloquine may increase the risk of convulsions.DailyMed (U.S. National Library of Medicine)

• Chloroquine phosphate: 4-Aminoquinoline anti-protozoal; precise mechanism unknown - may act against Plasmodium by concentrating in the parasite's acid vesicles and inhibiting haem polymerisation; active against erythrocytic forms (US label).